Phio Pharmaceuticals Corp
Price
FilingsNewest: 8-K, Director or officer changeSep 28 →Insiders1 insider bought $22,300 in 4 open-market buys. No sales.→HoldersJane Street 1.0%Geode 1.0%Vanguard 0.8%→Financing →PeersClosest companies: ERNA, VIVS, GALT→
From the filings
Figures
- Net income
- −$12.9Mlast 12 months
- Operating cash flow
- −$10.7Mlast 12 months
- Cash and equivalents
- $13.0Mat the last balance sheet
- Shares outstanding
- 11.6M shareson issue